awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q34050239-2F40033A-927D-4031-917F-82FD55727D58
Q34050239-2F40033A-927D-4031-917F-82FD55727D58
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34050239-2F40033A-927D-4031-917F-82FD55727D58
Efficacy of bevacizumab plus erlotinib versus erlotinib alone in advanced non-small-cell lung cancer after failure of standard first-line chemotherapy (BeTa): a double-blind, placebo-controlled, phase 3 trial.
P2860
Q34050239-2F40033A-927D-4031-917F-82FD55727D58
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34050239-2F40033A-927D-4031-917F-82FD55727D58
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
a93e3ef288d7f4128900efdbf09ab00016766b19
P2860
Molecular characteristics of bronchioloalveolar carcinoma and adenocarcinoma, bronchioloalveolar carcinoma subtype, predict response to erlotinib.